These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 18480702)

  • 21. Depression in Parkinson's disease: a double-blind, randomized, placebo-controlled pilot study of omega-3 fatty-acid supplementation.
    da Silva TM; Munhoz RP; Alvarez C; Naliwaiko K; Kiss A; Andreatini R; Ferraz AC
    J Affect Disord; 2008 Dec; 111(2-3):351-9. PubMed ID: 18485485
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Galantamine improves gait performance in patients with Alzheimer's disease.
    Assal F; Allali G; Kressig RW; Herrmann FR; Beauchet O
    J Am Geriatr Soc; 2008 May; 56(5):946-7. PubMed ID: 18454755
    [No Abstract]   [Full Text] [Related]  

  • 23. Continuation and long-term maintenance treatment with Hypericum extract WS 5570 after recovery from an acute episode of moderate depression--a double-blind, randomized, placebo controlled long-term trial.
    Kasper S; Volz HP; Möller HJ; Dienel A; Kieser M
    Eur Neuropsychopharmacol; 2008 Nov; 18(11):803-13. PubMed ID: 18694635
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Galantamine: excess mortality.
    Prescrire Int; 2005 Jun; 14(77):103. PubMed ID: 15986514
    [No Abstract]   [Full Text] [Related]  

  • 25. [Personality test and prediction of antidepressive treatment effect in mental illness].
    Nielsen S
    Ugeskr Laeger; 2010 Mar; 172(13):1068; author reply 1068. PubMed ID: 20411601
    [No Abstract]   [Full Text] [Related]  

  • 26. Why antidepressants are not antidepressants: STEP-BD, STAR*D, and the return of neurotic depression.
    Ghaemi SN
    Bipolar Disord; 2008 Dec; 10(8):957-68. PubMed ID: 19594510
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The modern pharmacopoeia: a return to depressive realism?
    Goldberg JF
    Bipolar Disord; 2008 Dec; 10(8):969-72. PubMed ID: 19594511
    [No Abstract]   [Full Text] [Related]  

  • 28. Sleepwalking associated with reboxetine in a young female patient with major depression--a case report.
    Künzel HE; Schuld A; Pollmächer T
    Pharmacopsychiatry; 2004 Nov; 37(6):307-8. PubMed ID: 15551201
    [No Abstract]   [Full Text] [Related]  

  • 29. Combination antidepressants are not yet proven therapy in the treatment of depression.
    Olver J; Ellen S; Norman T
    Australas Psychiatry; 2007 Jun; 15(3):248-9. PubMed ID: 17516193
    [No Abstract]   [Full Text] [Related]  

  • 30. Diabetes mellitus and major depressive disorder: an overview of prevalence, complications, and treatment.
    Carney C
    Depress Anxiety; 1998; 7(4):149-57. PubMed ID: 9706451
    [No Abstract]   [Full Text] [Related]  

  • 31. Augmentation strategies in the treatment of major depressive disorder. Clinical considerations with atypical antipsychotic augmentation.
    Gitlin MJ
    CNS Spectr; 2007 Dec; 12(12 Suppl 22):13-5. PubMed ID: 18389929
    [No Abstract]   [Full Text] [Related]  

  • 32. Diagnosis and treatment of a major depressive episode.
    Thase ME
    J Clin Psychiatry; 2009 Oct; 70(10):e37. PubMed ID: 19906336
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A new method in the treatment of migraine using anticholinesterase drugs (clinical observations)].
    Ikonomoff SI
    Schweiz Arch Neurol Neurochir Psychiatr; 1968; 102(2):299-312. PubMed ID: 5734592
    [No Abstract]   [Full Text] [Related]  

  • 34. Antidepressant treatment practice in the face of STAR*D and STEP-BD.
    Cassidy F
    Bipolar Disord; 2008 Dec; 10(8):973-4. PubMed ID: 19594512
    [No Abstract]   [Full Text] [Related]  

  • 35. Not all monoamine oxidase inhibitors are created equal.
    Stewart JT
    J Am Geriatr Soc; 2007 Nov; 55(11):1890. PubMed ID: 17979910
    [No Abstract]   [Full Text] [Related]  

  • 36. [Galantamine therapy in dementia associated with CADASIL].
    Posada IJ; Ferrero M; Lopez-Valdes E; Goni-Imizcoz M
    Rev Neurol; 2008 Sep 16-30; 47(6):299-300. PubMed ID: 18803156
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Likelihood to be helped or harmed can assist in clinical decision-making.
    Citrome L
    J Clin Psychiatry; 2011 Feb; 72(2):261-2; author reply 262. PubMed ID: 21382311
    [No Abstract]   [Full Text] [Related]  

  • 38. [Clinical evaluation of the antidepressive action of sulfoadenosyl-L-methionine compared with that of chlorimipramine].
    Giner Ubago J; González Infante JM; Blanco Picabia A
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1984; 12(1):73-80. PubMed ID: 6372376
    [No Abstract]   [Full Text] [Related]  

  • 39. Patterns of early change and their relationship to outcome and follow-up among patients with major depressive disorders.
    Lutz W; Stulz N; Köck K
    J Affect Disord; 2009 Nov; 118(1-3):60-8. PubMed ID: 19217669
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Results of treatment of depressive states with melitracen].
    Madejska N; Mika M; Pańkow T
    Psychiatr Pol; 1967; 1(4):463-71. PubMed ID: 5595168
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.